Keeping tabs on Covid-19
As emerging drug therapies and clinical trials to battle the spread of Covid-19 are publicized daily, pharma companies are coming under increased scrutiny from public health officials and health practitioners in the hunt to find a cure.
Pharma IQ’s Keeping tabs on Covid-19 highlights industry updates in pharma, dives into the latest research and treatment options, and explores innovative solutions coming out of pharma as it plays a vital role in fighting the pandemic.
Keeping tabs on Covid-19: Living with the virus
February 17 by Leila Hawkins
The UK is set to remove all Covid-19 rules in the coming days as the nation looks to return to normal, but around the world cases are still rising
Keeping tabs on Covid-19: A mixed picture around the world
January 25 by Leila Hawkins
Omicron peaks in some parts of Europe, but WHO warns this is not the end. Meanwhile Merck approves generic anti-viral for poorer nations
Keeping tabs on Covid-19: battling Omicron, Merck’s antiviral
December 09 by Leila Hawkins
As the world grapples with another Covid-19 variant, BioNTech and Pfizer announce it can be neutralized with three vaccinations, while new antiviral pills provide hope
Keeping tabs on Covid-19: Novavax develops combined Covid-flu vaccine and Rigel Pharmaceuticals reduces Covid-19 risks by 50 per cent
September 10 by Adam Jeffs
This update from Pharma IQ sheds light on recent clinical developments from the world of pharma in the global fight against Covid-19
Keeping tabs on Covid-19: Big pharma’s response to the global health emergency
August 20 by Emily Uwemedimo
The latest developments from Roche, Regeneron, AstraZeneca, Amgen and Merck as they progress with projects to tackle the Covid-19 pandemic
Keeping tabs on Covid-19: EMA approves Moderna vaccine for teens and Japan approves Roche–Regeneron’s treatment
July 30 by Emily Uwemedimo
The EMA recommends Moderna’s Covid-19 vaccine for 12–17 year olds as discussions continue with the FDA for approval for children in the US
Keeping tabs on Covid-19: Taiwan’s vaccine feud with China ends and South Africa registers more than 17,000 new Covid-19 cases
July 16 by Emily Uwemedimo
The sharp rise in Covid-19 infections in Taiwan has renewed the debated on whether the island’s government should allow drug imports to resume from mainland China
Keeping tabs on Covid-19: Japan declares state of emergency but plans for Olympics continue and initiative increases Covid-19 vaccine confidence in women of color
June 25 by Emily Uwemedimo
Women of Color in Pharma creates "We Are Pharma” initiative to address Covid-19 vaccination concerns in minority communities
Keeping tabs on Covid-19: The rise and fall of the Russian-made vaccine
June 04 by Emily Uwemedimo
Pending the review results from WHO and the EMA on Sputnik V, Russia hopes to squander its vaccine efficiency concerns
Keeping tabs on Covid-19: Asia lags in vaccine roll outs and new South Korean drug marked as a “game changer”
May 28 by Emily Uwemedimo
A “game changing” Covid-19 drug from South Korea has been introduced in a world-class academic journal
Keeping tabs on Covid-19: Debate intensifies over Covid-19 vaccine patent waiver
May 14 by Emily Uwemedimo
China and the US back vaccine waiver to help India’s Covid-19 crisis, while the UK and EU remain skeptical despite a willingness to discuss the proposal
Keeping tabs on Covid-19: India’s Covid-19 vaccine demand in crisis
April 30 by Emily Uwemedimo
The US has dispatched 20 million AstraZeneca vaccine doses to India in an attempt to curb its second wave
